Latest Janssen Inc. Stories
INVOKANA((TM) )offers a new approach to treatment TORONTO, May 26, 2014 /CNW/ - Janssen Inc. announced today that Health Canada has approved INVOKANA((TM) )(canagliflozin), an oral, once-daily prescription treatment used to lower blood glucose (sugar) levels in adults with type 2 diabetes.(1) INVOKANA((TM) )belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors that offers a novel approach to treating diabetes by increasing the loss of...
- To talk saucily.
- Insolent, opprobrious language; impertinent abuse.